BAY CITY CAPITAL LLC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-13 4:05 pm Sale | 2023-12-07 | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 567,644 2.900% | -1,469,496 (-72.14%) | Filing |
| 2021-12-07 4:30 pm Sale | 2021-12-03 | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 2,037,140 11.900% | -826,934 (-28.87%) | Filing |
| 2020-09-04 9:16 pm Sale | 2020-09-04 | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 2,864,074 18.600% | -1,441,005 (-33.47%) | Filing |
| 2020-06-01 5:19 pm Purchase | 2020-05-27 | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 4,305,079 27.900% | 127,225 (+3.05%) | Filing |